Ken Nelson

Ken Nelson is an experienced leader in the medical technology and digital health sectors, currently serving on the Board of Directors for Acarix and HeartBeam Inc., and as Chairman of the Board of Directors for CardiaCare, which is developing a wearable therapy for atrial fibrillation. Additionally, Nelson is a Partner at MedTech Advantage Fund, emphasizing venture investments in MedTech Innovator alumni companies, and holds a position on the AHA Health Technology Innovation Business Advisory Board, contributing insights on healthcare innovations. Previous roles include Head of Digital Health at BIOTRONIK, Chief Commercial Officer at Bardy Diagnostics, and Vice President of Sales roles at BioTelemetry Healthcare and iRhythm Technologies. Nelson holds a Bachelor of Arts in Economics, Business Administration, and Spanish from Vanderbilt University.